Search clinical trials for: Miltenyi CD34 Reagent System

Total 246952 results

Brigham and Women's Hospital
Johns Hopkins University; National Institute on Aging (NIA); Rutgers University

Active, not recruiting

Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Propranolol/Carvedilol Versus Atenolol/Bisoprolol/Sotalol

Hypertension

United States
Benovus Bio, Inc.

Unknown

Phase I Study of an Oncofetal Antigen Multi-Peptide Immunotherapy in Subjects With Hematologic Cancer (BBMPI03)

Myelodysplastic Syndrome (MDS) | Acute Myelogenous Leukemia (AML) | Multiple Myeloma (MM) | Smoldering Multiple Myeloma (sMM)

United States
Medical University of South Carolina

Recruiting

Metabolically Fit CD19 CAR T-cell Therapy With CD34 Selection in Patients With CD19+ Relapsed/Refractory NHL, CLL/SLL

Chronic Lymphocytic Leukemia | B-cell Non Hodgkin Lymphoma

United States
Memorial Sloan Kettering Cancer Center

Completed

A Study to Assess Thymic Function Using PET/CT and MRI

CD34 Selected Peripheral Blood Stem Cell Graft

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Recruiting

CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia

Recurrent Acute Myeloid Leukemia | Recurrent Chronic Myelomonocytic Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic Leukemia | Refractory Myelodysplastic Syndrome | Refractory Mixed Phenotype Acute Leukemia | Refractory Acute Leukemia... and other conditions

United States
Azienda Ospedaliera Universitaria Integrata Verona
University of Catania

Completed

Vortioxetine in the Elderly vs. Selective Serotonin Reuptake Inhibitors (SSRIs): a Pragmatic Assessment (VESPA)

Major Depressive Disorder

Italy
Assiut University

Completed

Supportive Measures in Treatment of Aluminum Phosphide Poisoning

Detection of Different Prognostic Factors and Their Relation With the Outcome | Using New Protocol to Prove the Role of N-acetyl Cysteine and Adequate Supportive Measures in Aluminum Phosphide Poisoning
University of Florida
National Heart, Lung, and Blood Institute (NHLBI); Pfizer

Completed

EWISE: Study of Eplerenone in Women With Chest Pain, Coronary Vascular Dysfunction and Evidence of Myocardial Ischemia

Ischemic Heart Disease

United States
National Cancer Institute (NCI)

Active, not recruiting

Onalespib, Dabrafenib, and Trametinib in Treating Patients With BRAF-Mutant Melanoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Metastatic Melanoma | Stage III Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Metastatic Malignant Solid Neoplasm | Stage IIIC Cutaneous Melanoma AJCC v7 | Unresectable Solid Neoplasm | BRAF V600E Mutation Present | BRAF V600K Mutation Present | Stage IIIA Cutaneous Melanoma... and other conditions

United States
Centre Hospitalier St Anne

Not yet recruiting

Prediction of the Therapeutic Response in Depression Based on Neuro-computational Modeling Assessment of Motivation (STRATIDEP)

Major Depressive Disorder

France
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Acute Myeloid Leukemia | Recurrent Hodgkin Lymphoma | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Chronic Myelomonocytic Leukemia | Acute Lymphoblastic Leukemia | Lymphoblastic Lymphoma | Myelodysplastic Syndrome | Plasma Cell Myeloma | Aplastic Anemia | Recurrent Non-Hodgkin... and other conditions

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Autologous Stem Cell Transplant Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoma

Refractory Hodgkin Lymphoma | Recurrent Adult Hodgkin Lymphoma | Recurrent Small Lymphocytic Lymphoma | Prolymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | T-Cell Chronic Lymphocytic Leukemia | Recurrent Childhood Non-Hodgkin... and other conditions

United States, Germany
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia

Waldenstrom Macroglobulinemia | Refractory Plasma Cell Myeloma | Recurrent Adult Hodgkin Lymphoma | Recurrent Adult Non-Hodgkin Lymphoma | Recurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Refractory Non-Hodgkin Lymphoma | Recurrent Plasma Cell Myeloma | Plasma Cell Leukemia and other conditions

United States
Mamatha Pasnoor, MD
Mallinckrodt

Withdrawn

Pilot Study of Acthar® Gel in Chronic Inflammatory Demyelinating Neuropathy

Chronic Inflammatory Demyelinating Polyneuropathy

United States
Fondazione EMN Italy Onlus

Active, not recruiting

Cyclophosphamide, Lenalidomide and Dexamethasone (CRD) Versus Melphalan (200 mg/m2) Followed By Autologous Stem Cell Transplant (ASCT) In Newly Diagnosed Multiple Myeloma Subjects

Multiple Myeloma

Italy
Fondazione EMN Italy Onlus

Active, not recruiting

Lenalidomide Melphalan and Prednisone Versus High Dose Melphalan in Newly Diagnosed Multiple Myeloma Patients (MPRvsMEL200)

Multiple Myeloma | Newly Diagnosed Patients

Italy
Stem Cells Arabia

Completed

Transplantation of Autologous Stem Cells for the Treatment of Type 1 Diabetes Mellitus

Glucose Metabolism Disorders | Metabolic Diseases | Immune System Diseases | Autoimmune Diseases | Endocrine System Diseases | Diabetes Mellitus Type 1

Jordan
Royal Brompton & Harefield NHS Foundation Trust

Completed

CMR to Assess Fibrosis in Cardiomyopathy Using Eplerenone

Cardiomyopathy

United Kingdom
Joseph Antin
Miltenyi Biomedicine GmbH

No longer available

CliniMACS® CD34+ Reagent System for Expanded Access Use

Graft Failure | Delayed Graft Function | Graft-Versus-Host Disease(GVHD) | Anemia Due to Disturbance of Proliferation and/or Differentiation of Hematopoietic Stem Cells

United States
TC Erciyes University

Unknown

Effect of Cell Surface Markers and Lymphoid Cell Distribution on the Arterial Tissue Repair (ECLAR) (ECLAR)

Injury of Radial Artery at Wrist and Hand Level | Injury; Ulnar Artery, Hand and Wrist

Turkey
University of New Mexico
National Cancer Institute (NCI)

Withdrawn

A Novel Magnetic Needle Using Iron Oxide Nanoparticles for the Detection of Leukemia

Leukemia

United States
University Hospital Inselspital, Berne

Active, not recruiting

CD34+ Selected ASCT for Aggressive Lymphomas (SAAL)

Malignant Non-Hodgkin Lymphomas

Switzerland
Joanne Kurtzberg, MD
Duke University; Miltenyi Biotec, Inc.

Available

Expanded Access to T-cell Depleted Haplo-Identical Stem Cells for Patients Receiving Haplo-Identical and Unrelated Cord Blood Transplants

Hematologic Malignancies | Immune Deficiencies | Inborn Errors of Metabolism Disorders

United States
Central Hospital, Nancy, France

Active, not recruiting

Eplerenone in Patients Undergoing REnal Transplant (EPURE TRANSPLANT) (EPURE)

End-stage Renal Disease

France
Biolab Sanus Farmaceutica

Withdrawn

Pharmacokinetics Study of Eplerenone Coated Tablets

Healthy Subjects | Pharmacokinetics | Fasting

Brazil
Tel-Aviv Sourasky Medical Center

Unknown

Eplerenone For the Treatment of Chronic Central Serous Chorioretinopathy

Central Serous Chorioretinopathy

Israel
bluebird bio

Completed

A Study Evaluating the Safety and Efficacy of the LentiGlobin BB305 Drug Product in β-Thalassemia Major Participants

β-thalassemia Major

United States, Australia, Thailand
University of Florence
Tuscany Region

Completed

Monocentric Trial: Stem Cell Emergency Life Threatening Limbs Arteriopathy (SCELTA) (SCELTA)

Critical Limb Ischemia

Italy
University of Colorado, Denver

Recruiting

Haploidentical CD34+ Selected Cells Combined With Single Unit Umbilical Cord Blood Transplant for Treatment of High-risk Hematologic Disorders

Hematologic Disorders

United States
Children's Hospital Medical Center, Cincinnati
Hoxworth Blood Center

Terminated

CD34+ Stem Cell Infusion to Augment Graft Function

Bone Marrow Failure | Waning Donor Chimerism | Waning Immune Function | Primary Immunodeficiency Disease(s)

United States
Baylor College of Medicine
The Methodist Hospital Research Institute; Center for Cell and Gene Therapy...

Recruiting

Ex Vivo T-Cell Depletion of Mobilized Peripheral Blood Stem Cells Via CD34-Selection (EXCESS)

Stem Cell Transplant | Allogeneic

United States
Great Ormond Street Hospital for Children NHS Foundation...

Recruiting

Lentiviral Gene Therapy for p47 AR-CGD

P47-Phox, Deficiency of

United Kingdom
Christopher Dvorak

Recruiting

A Feasibility Study Using CLINIMACS® for Alpha/Beta T-Cell Depletion in Stem Cell Transplant

Graft Vs Host Disease | Graft-versus-host-disease

United States
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

MDS (Myelodysplastic Syndrome) | Severe Aplastic Anemia

United States
Janssen-Cilag Pty Ltd

Completed

An Efficacy and Safety Study of Autologous Cluster of Differentiation 34 (CD34+) Hematopoietic Progenitor Cells Transduced With Placebo or an Anti- Human Immunodeficiency Virus Type 1 (HIV-1) Ribozyme (OZ1) in Participants With HIV-1 Infection

HIV-1

Australia
Indiana University School of Medicine

Terminated

A Phase I Trial of Alloreactive Cell Infusion Following Transplantation of Haplotype Cells in Patients With Myeloid Malignancies

Myelodysplastic Syndromes | Leukemia, Myeloid, Acute | Leukemia, Lymphoid | Leukemia, Myelogenous, Chronic

United States
University of California, Davis

Active, not recruiting

Clinical Trial of Autologous Intravitreal Bone-marrow CD34+ Stem Cells for Retinopathy

Diabetic Retinopathy | Retinitis Pigmentosa | Non-exudative Age-related Macular Degeneration | Retina Vein Occlusion | Hereditary Macular Degeneration

United States
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome

Myelodysplastic Syndrome (MDS) | Severe Aplastic Anemia | Hypo-Plastic MDS

United States
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Repeat Peripheral Blood Stem Cell Transplantation for Patients With Sickle Cell Disease and Falling Donor Myeloid Chimerism Levels

Myeloid Chimerism

United States
Imperial College London

Completed

Autologous Adult Stem Cells to Patients With Type 1 Diabetes and a Successful Renal Transplant

Type 1 Diabetes | Type 2 Diabetes

United Kingdom
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...

Completed

Biological Variables Affecting CD34+ Peripheral Cells Collection Efficiency (CD34+CE_2023)

Optimize PBSC Harvest Through Automated Buffy Coat

Italy
Shenzhen Second People's Hospital
Guangzhou Women and Children's Medical Center; Shenzhen University

Recruiting

Autologous Hematopoietic Stem Cell Gene Therapy for Metachromatic Leukodystrophy and Adrenoleukodystrophy

Adrenoleukodystrophy | Metachromatic Leukodystrophy

China
Great Ormond Street Hospital for Children NHS Foundation...

Recruiting

Lentiviral Gene Therapy for X-linked Severe Combined Immunodeficiency

Severe Combined Immunodeficiency, X-Linked

United Kingdom
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Gene Therapy for the Treatment of Fanconi's Anemia Type C

Pancytopenia | Fanconi's Anemia

United States
Minovia Therapeutics Ltd.

Completed

A Study to Evaluate the Safety and Therapeutic Effects of Transplantation of MNV-BM-BLD in Pediatric Patients With Pearson Syndrome

Mitochondrial Diseases | Pearson Syndrome

Israel
Hamilton Health Sciences Corporation
McMaster University; Canadian Breast Cancer Research Alliance; Ontario Cancer...

Completed

Administration of Autologous Dendritic Cells (DCs) Infected With an Adenovirus Expressing Her-2

Breast Neoplasms

Canada
Lisata Therapeutics, Inc.

Completed

Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina (RENEW)

Refractory Angina Pectoris | Chronic Myocardial Ischemia | Advanced Coronary Heart Disease

United States
Children's Mercy Hospital Kansas City
University of Kansas

Completed

Allogeneic Stem Cell Transplantation for Advanced Neuroblastoma Using MHC Mismatched Related Donors (STALLO)

Neuroblastoma

United States
Foundation for Biomedical Research and Innovation
Institute of Biomedical Research and Innovation, Kobe, Hyogo, Japan; Kobe City... and other collaborators

Terminated

Stem Cell Study for Patients With Heart Disease

Myocardial Infarction | Coronary Artery Disease | Chest Pain | Angina | Chronic Myocardial Ischemia

Japan
Johann Wolfgang Goethe University Hospital
German Federal Ministry of Education and Research

Unknown

Gene Therapy for Chronic Granulomatous Disease (CGD)

Granulomatous Disease, Chronic

Germany

Search clinical trials for: Miltenyi CD34 Reagent System

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uzbekistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations